2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Alcohol: new trials by email Literature Review of Alcohol trials Research Report on Alcohol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV Semaglutide (Rybelsus®), Placebo - HIV, Alcohol | Phase 2 | Recruiting | Vanderbilt University Medical Center | 200 | 2026-04-17 | 2026-05-26 |
| Tirzepatide for Alcohol Use Disorder Tirzepatide, Placebo injections - Alcohol Use Disorder, Obesity and Overweight | Phase 2 | Recruiting | University of Southern California | 42 | 2025-10-06 | 2025-10-14 |
Alcoholism (1) · Behavior, Addictive (1) · Cardiovascular Diseases (1) · Cigarette Smoking (1) · Obesity (1) · Overweight (1) · Smoking (1)
Behavior (2) · Alcohol-Related Disorders (1) · Body Weight (1) · Chemically-Induced Disorders (1) · Compulsive Behavior (1) · Impulsive Behavior (1) · Mental Disorders (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Substance-Related Disorders (1) · Tobacco Smoking (1) · Tobacco Use (1)
Tirzepatide (1) · semaglutide (1)
University of Southern California (1) · Vanderbilt University Medical Center (1)
United States (2)
P60AA032176 (1), R21AA031892 (1)